Proton pump inhibitors and the risk of colorectal cancer

Journal of Clinical Gastroenterology

Volumn 45, Issue 2, 2011, Pages 177-

  Chen, Shicai ^a   Song, Xinming ^a   Gao, Xiang ^a   Li, Mingzhe ^a   Chen, Zhihui ^a   He, Yulong ^a   Zhan, Wenhua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LETTER; META ANALYSIS (TOPIC); PRIORITY JOURNAL;

COLORECTAL NEOPLASMS; HUMANS; PEPTIC ULCER; PROTON PUMP INHIBITORS; PROTON PUMPS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78951481495     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181ea181e     Document Type: Letter

References (7)

1. Greenland S. A critical look at some popular meta-analytic methods. Am J Epidemiol. 1994;140:290-296.
2. Emerson JD, Burdick E, Hoaglin DC, et al. An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. Control Clin Trials. 1990;11:339-352.
3. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting- Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA. 2000;283:2008-2012.
4. Robertson DJ, Larsson H, Friis S, et al. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology. 2007; 133:755-760.
5. Yang YX, Hennessy S, Propert K, et al. Chronic proton pump inhibitor therapy and the risk of colorectal cancer. Gastroenterology. 2007;133:748-754.
6. Van Soest EM, van Rossum LG, Dieleman JP, et al. Proton pump inhibitors and the risk of colorectal cancer. Am J Gastroenterol. 2008;103:966-973.
7. Chubak J, Boudreau DM, Rulyak SJ, et al. Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiol Drug Saf. 2009;18:540-544.